These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 105787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Bacteriologic cure of experimental Pseudomonas keratitis.
    Davis SD, Sarff LD, Hyndiuk RA.
    Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):916-8. PubMed ID: 100471
    [Abstract] [Full Text] [Related]

  • 4. Relative efficacy of the topical use of amikacin, gentamicin and tobramycin in experimental Pseudomonas keratitis.
    Davis SD, Sarff LD, Hyndiuk RA.
    Can J Ophthalmol; 1980 Jan; 15(1):28-9. PubMed ID: 6769572
    [Abstract] [Full Text] [Related]

  • 5. A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Bu P, Riske PS, Zaya NE, Carey R, Bouchard CS.
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):213-20. PubMed ID: 17593004
    [Abstract] [Full Text] [Related]

  • 6. Iontophoresis of tobramycin for the treatment of experimental Pseudomonas keratitis in the rabbit.
    Rootman DS, Hobden JA, Jantzen JA, Gonzalez JR, O'Callaghan RJ, Hill JM.
    Arch Ophthalmol; 1988 Feb; 106(2):262-5. PubMed ID: 3124801
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.
    Engel LS, Callegan MC, Hobden JA, Reidy JJ, Hill JM, O'Callaghan RJ.
    Curr Eye Res; 1995 Mar; 14(3):229-34. PubMed ID: 7796606
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic therapy of experimental Pseudomonas keratitis in guinea pigs.
    Davis SD, Sarff LD, Hyndiuk RA.
    Arch Ophthalmol; 1977 Sep; 95(9):1638-43. PubMed ID: 197908
    [Abstract] [Full Text] [Related]

  • 9. Treatment of experimental Pseudomonas keratitis using collagen shields containing tobramycin.
    Hobden JA, Reidy JJ, O'Callaghan RJ, Hill JM, Insler MS, Rootman DS.
    Arch Ophthalmol; 1988 Nov; 106(11):1605-7. PubMed ID: 3142450
    [Abstract] [Full Text] [Related]

  • 10. [Studies of tobramycin eye drops. Report 3. Therapeutic effect in experimental Peudomonas keratitis (author's transl)].
    Oishi M, Nishizuka K, Motoyama M, Ogawa T.
    Nippon Ganka Gakkai Zasshi; 1977 Nov 10; 81(11):1783-6. PubMed ID: 613826
    [No Abstract] [Full Text] [Related]

  • 11. Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa.
    Hobden JA, O'Callaghan RJ, Hill JM, Reidy JJ, Rootman DS, Thompson HW.
    Curr Eye Res; 1989 Nov 10; 8(11):1163-9. PubMed ID: 2515036
    [Abstract] [Full Text] [Related]

  • 12. Effect of minimal antibiotic treatment on bacterial keratitis.
    Hodges EJ, Friedlaender MH, Lee A, Okumoto M.
    Cornea; 1989 Sep 10; 8(3):188-90. PubMed ID: 2501067
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis.
    McCormick C, Caballero A, Tang A, Balzli C, Song J, O'Callaghan R.
    Curr Med Res Opin; 2008 Jun 10; 24(6):1569-75. PubMed ID: 18423106
    [Abstract] [Full Text] [Related]

  • 14. Corticosteroid in experimentally induced Pseudomonas keratitis: failure of prednisolone to impair the efficacy of tobramycin and carbenicillin therapy.
    Davis SD, Sarff LD, Hyndiuk RA.
    Arch Ophthalmol; 1978 Jan 10; 96(1):126-8. PubMed ID: 414703
    [Abstract] [Full Text] [Related]

  • 15. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK, Kowalski RP, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2004 Aug 10; 138(2):226-30. PubMed ID: 15289131
    [Abstract] [Full Text] [Related]

  • 16. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
    Clinch TE, Hobden JA, Hill JM, O'Callaghan RJ, Engel LS, Kaufmann HE.
    CLAO J; 1992 Oct 10; 18(4):245-7. PubMed ID: 1424060
    [Abstract] [Full Text] [Related]

  • 17. Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
    Lauffenburger MD, Cohen KL.
    Cornea; 1993 Nov 10; 12(6):517-21. PubMed ID: 8261784
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of tobramycin drops applied to collagen shields for experimental staphylococcal keratitis.
    Callegan MC, Engel LS, Clinch TE, Hill JM, Kaufman HE, O'Callaghan RJ.
    Curr Eye Res; 1994 Dec 10; 13(12):875-8. PubMed ID: 7720394
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis.
    Reidy JJ, Hobden JA, Hill JM, Forman K, O'Callaghan RJ.
    Cornea; 1991 Jan 10; 10(1):25-8. PubMed ID: 1902152
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
    Levy J, Baran D, Klastersky J.
    J Antimicrob Chemother; 1982 Sep 10; 10(3):227-34. PubMed ID: 6815155
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.